Skip to main content
HairCited

Oral zinc therapy for zinc deficiency-related telogen effluvium.

Tadashi Karashima, Daisuke Tsuruta, Takahiro Hamada, Fumitake Ono, Norito Ishii et al.
Case Report Dermatologic therapy 2012 31 인용
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D22741940'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

연구 유형
Case Reports
표본 크기
5
중재
Oral zinc therapy for zinc deficiency-related telogen effluvium. oral zinc administration as polaprezinc (Promac®)
대조군
Placebo
효과 방향
Positive
비뚤림 위험
High

Abstract

Zinc is crucial for maintaining human body homeostasis and is one of the major components of hormones, signal molecules, and enzymes. Zinc deficiency is caused by insufficient uptake of zinc from food, or caused by malabsorption syndromes, increased gastrointestinal and urinary losses, and administration of various medications. In order to test whether oral zinc administration can successfully improve zinc deficiency-related alopecia, we treated five patients with zinc deficiency-related telogen effluvium with oral zinc administration in the form of polaprezinc (Promac®). In all patients, hair loss was cured or improved. The administration of zinc for zinc deficiency-related alopecia may recover appropriate activities of metalloenzymes, hedgehog signaling, and immunomodulation, all of which are required for normal control of hair growth cycle.

Used In Evidence Reviews

Similar Papers